Literature DB >> 12786979

Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro.

Hideki Hida1, Cha-Gyun Jung, Chen-Zhen Wu, Hye-Jung Kim, Yuji Kodama, Tadashi Masuda, Hitoo Nishino.   

Abstract

To understand what kind of trophic factors are up-regulated in dopamine (DA)-depleted striatum, we first analysed the up-regulation of mRNAs using a DNA microarray in DA-depleted striatum where DAergic inputs were denervated by 6-OHDA. We then investigated whether or not such trophic factors had an effect on cultured dopaminergic neurons. The microarray analysis revealed that pleiotrophin (PTN), glial-derived neurotopic factor (GDNF) and others were up-regulated in DA-depleted striatum. As PTN has been reported to have a wide range of trophic effects on neurons, we focused on the functional role of PTN in the present study. The increase in PTN mRNA was confirmed by Northern blotting at 1-3 weeks after the lesion, reaching a peak at 1 week. In embryonic day 15 mesencephalic neuron culture, PTN increased the number of tyrosine hydroxylase (TH) -positive neurons in a dose-dependent manner (125.2 +/- 2.0% of the control at 50 ng/mL), while a family protein, midkine (10 ng/mL) did not show any trophic effect (99.3 +/- 0.7%). In addition, the PTN effect on DAergic neurons was additive to the GDNF effect. As PTN did not increase the number of microtubule-associated protein-2 (MAP 2)-positive neurons or promote the proliferation of dopaminergic progenitors in a bromodeoxyuridine (BrdU) labelling study, the effect appeared to enhance the specific survival of dopaminergic neurons. Expression of PTN receptors (syndecan-3, PTP-zeta) was detected on the cultured mesencephalic neurons, and also up-regulated in DA-depleted striatum. The data indicate that PTN is up-regulated in DA-depleted striatum and exhibits a trophic effect specifically on the survival of cultured dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12786979     DOI: 10.1046/j.1460-9568.2003.02661.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

1.  Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.

Authors:  Sara E Gombash; Jack W Lipton; Timothy J Collier; Lalitha Madhavan; Kathy Steece-Collier; Allyson Cole-Strauss; Brian T Terpstra; Anne L Spieles-Engemann; Brian F Daley; Susan L Wohlgenant; Valerie B Thompson; Fredric P Manfredsson; Ronald J Mandel; Caryl E Sortwell
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

Review 2.  The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Authors:  C Winkler; S Yao
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

4.  PAd-shRNA-PTN reduces pleiotrophin of pancreatic cancer cells and inhibits neurite outgrowth of DRG.

Authors:  Jun Yao; Min Zhang; Qing-Yong Ma; Zheng Wang; Lian-Cai Wang; Dong Zhang
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 5.  Pleiotrophin promotes perineural invasion in pancreatic cancer.

Authors:  Jun Yao; Xiu-Feng Hu; Xiao-Shan Feng; She-Gan Gao
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

6.  Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways.

Authors:  S E Gombash; F P Manfredsson; R J Mandel; T J Collier; D L Fischer; C J Kemp; N M Kuhn; S L Wohlgenant; S M Fleming; C E Sortwell
Journal:  Gene Ther       Date:  2014-05-08       Impact factor: 5.250

7.  Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells.

Authors:  Tandis Vazin; Jia Chen; Chun-Ting Lee; Rose Amable; William J Freed
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

Review 8.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

Review 9.  Pleiotrophin and peripheral nerve injury.

Authors:  Li Jin; Chen Jianghai; Liu Juan; Kang Hao
Journal:  Neurosurg Rev       Date:  2009-05-08       Impact factor: 3.042

10.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.